Kotak adds 5 new midcap stocks which fell up to 16% in one month to its model portfolio. Take a look

In response to recent market fluctuations, Kotak Institutional Equities has revamped its model portfolio, strategically introducing five mid-cap stocks that have seen notable price reductions. Among the new additions are Aster DM Quality Care and Dixon Tech, both showcasing promising upside potential. Alongside them, Emcure Pharmaceuticals and Endurance Technologies highlight substantial growth opportunities despite ongoing market corrections.